Synopsis As Introduced Creates the MRSA Screening and Reporting Act and amends the Hospital Licensing Act. Requires every hospital to establish a methicillin-resistant Staphylococcus aureus (MRSA) control program, and sets forth items that must be included in such a program. Provides that for all hospital patients who are identified with nosocomial S. aureus bloodstream infection or asymptomatic colonization due to MRSA, the Department of Public Health shall require the annual reporting of such cases as a communicable disease or condition. Requires the Department to compile aggregate data from all hospitals for all such patients and to make such data available on its website and in all reports on health statistics and reportable communicable disease cases in Illinois. In provisions of the Hospital Licensing Act concerning the reporting of communicable reportable diseases and conditions, provides that after the effective date of the amendatory Act, such reportable diseases and conditions shall include nosocomial Staphylococcus aureus bloodstream infections and asymptomatic colonization due to MRSA.
Replaces everything after the enacting clause. Reinserts provisions substantially similar to those of Senate Bill 233, creating the MRSA Screening and Reporting Act, but with changes that include the following: (1) eliminates definitions of "MRSA" and "MSSA"; (2) makes changes with respect to features that must be included in a hospital's MRSA control program; (3) provides that after October 1, 2007, the Department of Public Health shall compile aggregate data for all hospitals on the total number of infections due to MRSA that (i) are present on admission to a hospital and (ii) occurred during the hospital stay and shall make such data available on its web site, in an annual report, and on the Hospital Report Card; (4) eliminates provisions concerning reporting of certain cases of infection to the Department by hospitals; (5) repeals the Act on January 1, 2011; and (6) eliminates provisions amending the Hospital Licensing Act. Effective immediately.
Fiscal Note (Dept. of Public Health)
The Department estimates the fiscal impact of SB 233 at approximately $95.6 thousand for full year of implementation. This cost includes the addition of an Infection Control Specialist and subsequent operational costs.